Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Congenital Abnormality
|
3
|
9
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
MAGT1 Deficiency
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Sebaceous hyperplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Angiosarcoma of liver
|
disease |
Digestive System Diseases; Neoplasms; Cardiovascular Diseases
|
Neoplastic Process
|
11
|
1
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Granulomatous Slack Skin
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
22
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Dermatitis, Irritant
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hypothalamic hamartomas
|
disease |
Neoplasms; Nervous System Diseases
|
Congenital Abnormality
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Mycosis fungoides/Sezary syndrome NOS
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
36
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Type II Mucolipidosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
43
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
X-Linked Lymphoproliferative Disorder
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
49
|
10
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Oral candidiasis
|
disease |
Infections; Stomatognathic Diseases
|
Disease or Syndrome
|
58
|
2
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Richter's syndrome
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
61
|
1
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Disruptive, Impulse Control, and Conduct Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
67
|
9
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Glucose measurement
|
phenotype |
|
Laboratory Procedure
|
89
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
elevated blood glucose level
|
phenotype |
|
Finding
|
89
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Adult Angiosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
101
|
1
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Childhood Angiosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
101
|
1
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Maturity onset diabetes mellitus in young
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
105
|
49
|
0.020 |
None |
1.000 |
2 |
|
1992 |
1993 |
Angioimmunoblastic Lymphadenopathy
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
109
|
8
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2019 |
Hemoglobin measurement
|
phenotype |
|
Laboratory Procedure
|
131
|
224
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Hematocrit procedure
|
phenotype |
|
Laboratory Procedure
|
138
|
216
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Luminal A Breast Carcinoma
|
disease |
|
Neoplastic Process
|
153
|
11
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hemangiosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
162
|
7
|
0.550 |
None |
1.000 |
5 |
|
2014 |
2017 |
Urticaria
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
168
|
11
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Miller Dieker syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
182
|
9
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |